| TIME | ARTICLE |
JOURNAL |
IF | PUBMED ID | PRODUCT |
|---|---|---|---|---|---|
| 2024 | The novel role of LOC344887 in the enhancement of hepatocellular carcinoma progression via modulation of SHP1-regulated STAT3/HMGA2 signaling axis | International Journal of Biological Sciences | 8.2 | 39664573 | |
| 2024 | The colony-stimulating factor-1 receptor inhibitor edicotinib counteracts multidrug resistance in cancer cells by inhibiting ABCG2-mediated drug efflux | Biomedicine & Pharmacotherapy | 6.9 | 39405897 | |
| 2024 | Epertinib counteracts multidrug resistance in cancer cells by antagonizing the drug efflux function of ABCB1 and ABCG2 | Biomedicine & Pharmacotherapy | 6.9 | 39388999 | |
| 2024 | LARP3, LARP7, and MePCE are involved in the early stage of human telomerase RNA biogenesis | Nature communications | 14.7 | 39009594 | |
| 2024 | ABCG2 Mediates Resistance to the Dual EGFR and PI3K Inhibitor MTX-211 in Cancer Cells | International Journal of Molecular Sciences | 4.9 | 38791198 | |
| 2024 | EGFR targeting PhosTACs as a dual inhibitory approach reveals differential downstream signaling | Science Advances | 13.6 | 38536914 | |
| 2024 | Endothelial Mitochondria Transfer to Melanoma Induces M2-Type Macrophage Polarization and Promotes Tumor Growth by the Nrf2/HO-1-Mediated Pathway | International Journal of Molecular Sciences | 5.6 | 38339136 | |
| 2023 | The epidermal growth factor receptor inhibitor mobocertinib resensitizes multidrug-resistant cancer cells by attenuating the human ATP-binding cassette subfamily B member 1 and subfamily G member 2. | ACS Pharmacology & Translational Science | 6 | 38230272 | |
| 2023 | Dual antibody-aided mesoporous nanoreactor for H2O2 self-supplying chemodynamic therapy and checkpoint blockade immunotherapy in triple-negative breast cancer | Journal of Nanobiotechnology | 10.2 | 38129849 |
